Endometriosis—the role of medroxyprogesterone acetate

References

• Barbieri R. L., Ryan K. J. Medical therapy for endometriosis: endocrine pharmacology. Seminars in Reproductive Endocrinology 1985; 3: 339–352
   Google Scholar
• Barbieri R. L. Hormonal therapy of endometriosis. Infertility and Reproductive Medicine Clinics of North America 1992; 3: 187–200
   Google Scholar
• Bergquist A., Feno M. Steroid receptors in endometriotic tissue and endometrium assay with monoclonal antibodies. Recent Research in Gynecological Endocrinology, A. R. Genazzani. Parthenon, Carnforth 1988; volume I: 394
   Google Scholar
• Candiani G. B., Vercellini P., Fedele L. Laparoscopic ovarian puncture for correct staging of endometriosis. Fertility und Sterility 1990; 53: 994–997
   Google Scholar
• Di Zerega G. S., Barber D. L., Hodgen G. D. Endometriosis: role of ovarian steroids in initiation, maintenance and suppression. Fertility and Sterility 1980; 33: 649–653
   Google Scholar
• Dmowski W. P., Cohen M. R. Antigonadotropin (danazol) in the treatment of endometriosis: evaluation of post-treatment fertility and three year followup data. American Journal of Obstetrics und Gynecology 1978; 130: 41–48
   Google Scholar
• Evers J. L. H. The second-look laparoscopy for evaluation of the result of medical treatment of endometriosis should not be performed during ovarian suppression. Fertility and Sterility 1987; 47: 502–504
   PubMed Web of Science ®Google Scholar
• Hassan H. M. Incidence of endometriosis in diagnostic laparoscopy. Journal of Reproductive Medicine 1976; 16: 135–138
   PubMedGoogle Scholar
• Henzl M. R., Corson S. L., Moghissi K., Buttram V. C., Bergqvist C., Jacobsen J. Administration of nasal nafarelin as compared with oral danazol for endometriosis: a multicentered double-blind comparative clinical trial. New England Journal of Medicine 1988; 318: 485–489
   PubMed Web of Science ®Google Scholar
• Karnaky K. H. The use of stilbestrol for endometriosis. Preliminary report. Southern Medical Journal 1948; 41: 1109–1111
   PubMedGoogle Scholar
• Kaupilla A., Isomaa V., Ronnberg L., Vierikko P., Vikko R. Effect of gestrinone in endometriosis tissue and endometrium. Fertility and Sterility 1985; 44: 466–470
   Google Scholar
• Kistner R. The treatment of endometriosis by inducing pseudopregnancy with ovarian hormones. A report of 58 cases. Fertility and Sterility 1959; 10: 539–543
   Web of Science ®Google Scholar
• Luciano A. A., Hauser K. S. D., Chapler F. K., Sherman B. M. Danazol: endocrine consequences in healthy women. American Journal of Obstetrics and Gynecology 1981; 141: 723–727
   Google Scholar
• Luciano A. A., Hauser K. S., Chapler F. K., Davies W. A., Wallace R. B. Effects of danazol on plasma lipid and lipoprotein levels in healthy women and in women with endometriosis. American Journal of Obstetrics and Gynecology 1983; 145: 422–426
   Google Scholar
• Luciano A. A., Turksoy R. N., Carleo J. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. Obstetrics and Gynecology 1988a; 12: 323–327
   Google Scholar
• Luciano A. A., Turksoy R. N., O'Boyle L. (1988b) Oral medroxyprogesterone acetate suppresses testosterone-estradiol binding globulin but not cortico-steroid binding globulin in the treatment of endometriosis. Abstract #724, 70th Annual Meeting of The Endocrine Society. June, 8–111988. Louisiana, New Orleans
   Google Scholar
• Luciano A. A., Metzger D. A. Endometriosis—what can medical therapy offer. British Journal of Clinical Practice 1991; 72(Autumn supplement)14–23
   Google Scholar
• Martin D. C., Hubert G. D., Vander-Zwaag R., ElZeky F. A. Laparoscopic appearances of peritoneal endometriosis. Fertility and Sterility 1989; 51: 63–67
   Google Scholar
• Moghissi K. S., Boyce C. R. Management of endometriosis with oral medroxyprogesterone acetate. Obstetrics and Gynecology 1976; 41: 265–267
   Google Scholar
• Noble A. D., Letchworth A. T. Preliminary observations on the use of danazol in endometriosis compared to estrogen/progestogen combination therapy. Journal of International Medical Research 1977; 5(supplement 3)79–80
   Google Scholar
• Punnonen R., Pettersson K., Vanharanta R., Lukola A. Androgen, estrogen. and progestin binding in cytosols of benign gynecologic tumors and tumor like lesions. Hormone and Metabolic Research 1985; 17: 607
   Google Scholar
• Roland M., Leistein D., Kane R. Endometriosis therapy with medroxyprogesterone acetate. Journal of Reproductive Medicine 1976; 11: 249–252
   Google Scholar
• Sampson J. A. Heterotopic or misplaced endometrial tissue. American Journal of Obstetrics and Gynecology 1925; 10: 659–662
   Google Scholar
• Schmidt C. L. Endometriosis: a reappraisal of pathogenesis and treatment. Fertility and Sterility 1985; 44: 157–173
   PubMed Web of Science ®Google Scholar
• Scott R. B., Wharton L. R. Effects of progesterone and norethindrone on experimental endometriosis in monkeys. American Journal of Obstetrics and Gynecology 1962; 84: 867–875
   PubMed Web of Science ®Google Scholar
• Telimaa S., Puolakka J., Ronnberg L., Kauppila A. Placebo-controlled comparison of danazol and high dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecological Endocrinology 1987a; 1: 13–23
   PubMedGoogle Scholar
• Telimaa S., Ronnberg L., Kauppila A. Placebo-controlled comparison of danazol and high dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery. Gynecological Endocrinology 1987b; 1: 363–371
   PubMedGoogle Scholar
• Vasquez G., Cornillie F., Brosens I. A. Peritoneal endometriosis: scanning electron microscopy and histology of minimal pelvic endometriotic lesions. Fertility and Sterility 1984; 42: 696–703
   Google Scholar
• Williams T. J., Pratt J. H. L. Endometriosis in a 1000 consecutive celiotomies: incidence and management. American Journal of Obstetrics and Gynecology 1977; 129: 245–250
   PubMed Web of Science ®Google Scholar